| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | - | |
Moiz Rehmanjee
DFI | Director of Finance/CFO | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 01/10/2016 | |
| Chairman | - | 27/10/2017 | |
| Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 2.49Cr | |
| -2.21% | -3.11% | +52.16% | +91.64% | 1,00200Cr | |
| -2.22% | -0.76% | +51.08% | +67.61% | 65TCr | |
| -2.99% | -4.31% | +18.59% | +66.94% | 44TCr | |
| -0.88% | +0.86% | +29.77% | +36.54% | 35TCr | |
| -0.32% | -14.63% | +9.27% | +26.87% | 26TCr | |
| -0.01% | -0.72% | -0.79% | +9.50% | 25TCr | |
| -10.08% | -10.26% | +40.32% | +51.55% | 21TCr | |
| -0.35% | -0.65% | -15.84% | -56.91% | 20TCr | |
| -2.88% | -2.19% | +26.54% | +92.95% | 18TCr | |
| Average | -3.25% | -2.06% | +23.46% | +42.97% | 39.37TCr | |
| Weighted average by Cap. | -2.32% | -2.39% | +32.82% | +57.45% |
Employees
-
Sector
Pharmaceuticals
